title: The modifying effects of indomethacin or ascorbic acid on cell proliferation induced by different types of bladder tumor promoters in rat urinary bladder and forestomach mucosal epithelium.
abstract: The effects of indomethacin (IM) or L-ascorbic acid (AsA) on cell proliferation induced by bladder tumor promoters such as butylated hydroxyanisole (BHA), sodium L-ascorbate (Na-AsA), sodium citrate (Na-Cit), and diphenyl (DP) in rat bladder and forestomach epithelium were investigated. Treatment with IM in combination with BHA or Na-AsA diminished DNA synthesis levels of bladder epithelium as compared to the BHA or Na-AsA alone values. On the other hand, AsA further amplified the increase of bladder epithelial DNA synthesis caused by Na-Cit treatment. Histopathologically, administration of Na-AsA in combination with IM reduced the incidence of simple hyperplasia. In contrast, simultaneous treatment with Na-Cit and AsA caused an increase of the hyperplasia development. No apparent combination effects were observed in the DP-treated groups. In forestomach epithelium, AsA enhanced the BHA-induced increase in DNA synthesis and epithelial hyperplasia, characterized by marked basal cell proliferation. The present results thus suggested that IM may exert inhibitory effects on promotion of bladder carcinogenesis by certain tumor promoter types, and AsA may enhance BHA forestomach carcinogenesis.
authors.affiliation: First Department of Pathology, Nagoya City University Medical School.
authors.forename: M A
authors.initials: MA
authors.lastname: Shibata
authors.forename: S
authors.initials: S
authors.lastname: Fukushima
authors.forename: E
authors.initials: E
authors.lastname: Asakawa
authors.forename: M
authors.initials: M
authors.lastname: Hirose
authors.forename: N
authors.initials: N
authors.lastname: Ito
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D002083:Butylated Hydroxyanisole / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002951:Citrates / Q000494:pharmacology; D019343:Citric Acid; D004347:Drug Interactions; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D005753:Gastric Mucosa / Q000187:drug effects* / Q000473:pathology; D006965:Hyperplasia / Q000139:chemically induced; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D001743:Urinary Bladder / Q000187:drug effects* / Q000473:pathology
chemical_list: D002273:Carcinogens; D002951:Citrates; D002083:Butylated Hydroxyanisole; D019343:Citric Acid; D001205:Ascorbic Acid; D007213:Indomethacin